Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial

Lidewij Warris; Marry Van den Heuvel - Eibrink; Femke Aarsen; Saskia Pluijm; MB Bierings; C van den Bos; C.M. Zwaan; HH Thygesen; WJE Tissing; MA Veening; Rob Pieters; Erica van den Akker

doi:10.1200/JCO.2015.66.0761

Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial

Lidewij Warris
, Marry Van den Heuvel - Eibrink
, Femke Aarsen
, Saskia Pluijm
, MB Bierings
, C van den Bos
, C.M. Zwaan
, HH Thygesen
, WJE Tissing
, MA Veening
, Rob Pieters
, Erica van den Akker

Pediatrics

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

67 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	2287-+
Journal	Journal of Clinical Oncology
Volume	34
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2015.66.0761
Publication status	Published - 2016

Research programs

EMC MM-01-54-01
EMC MM-02-54-03

Access to Document

10.1200/JCO.2015.66.0761

REPUB_97475_OA.pdfFinal published version, 810 KB

Cite this

Warris, L., Van den Heuvel - Eibrink, M., Aarsen, F., Pluijm, S., Bierings, MB., van den Bos, C., Zwaan, C. M., Thygesen, HH., Tissing, WJE., Veening, MA., Pieters, R., & van den Akker, E. (2016). Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. Journal of Clinical Oncology, 34(19), 2287-+. https://doi.org/10.1200/JCO.2015.66.0761

@article{ab0eded6df4f48fb89b60bfd8e648ba3,

title = "Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial",

author = "Lidewij Warris and \{Van den Heuvel - Eibrink\}, Marry and Femke Aarsen and Saskia Pluijm and MB Bierings and \{van den Bos\}, C and C.M. Zwaan and HH Thygesen and WJE Tissing and MA Veening and Rob Pieters and \{van den Akker\}, Erica",

year = "2016",

doi = "10.1200/JCO.2015.66.0761",

language = "Undefined/Unknown",

volume = "34",

pages = "2287--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "19",

}

Warris, L, Van den Heuvel - Eibrink, M, Aarsen, F, Pluijm, S, Bierings, MB, van den Bos, C, Zwaan, CM, Thygesen, HH, Tissing, WJE, Veening, MA, Pieters, R & van den Akker, E 2016, 'Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial', Journal of Clinical Oncology, vol. 34, no. 19, pp. 2287-+. https://doi.org/10.1200/JCO.2015.66.0761

Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. / Warris, Lidewij; Van den Heuvel - Eibrink, Marry; Aarsen, Femke et al.
In: Journal of Clinical Oncology, Vol. 34, No. 19, 2016, p. 2287-+.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial

AU - Warris, Lidewij

AU - Van den Heuvel - Eibrink, Marry

AU - Aarsen, Femke

AU - Pluijm, Saskia

AU - Bierings, MB

AU - van den Bos, C

AU - Zwaan, C.M.

AU - Thygesen, HH

AU - Tissing, WJE

AU - Veening, MA

AU - Pieters, Rob

AU - van den Akker, Erica

PY - 2016

Y1 - 2016

U2 - 10.1200/JCO.2015.66.0761

DO - 10.1200/JCO.2015.66.0761

M3 - Article

C2 - 27161966

SN - 0732-183X

VL - 34

SP - 2287-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 19

ER -